Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
MBIO Quote, Financials, Valuation and Earnings
Last price:
$2.21
Seasonality move
:
-30.19%
Day range:
$2.02 - $2.37
52-week range:
$0.89 - $24.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.81x
Volume:
850.5K
Avg. volume:
11.9M
1-year change:
-87.38%
Market cap:
$10.2M
Revenue:
--
EPS (TTM):
-$20.07
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $47.3M | $55.7M | $63.9M | $41M | $8.4M | |
| Selling, General & Admin | $9.5M | $11M | $12.2M | $9.7M | $4.1M | |
| Other Inc / (Exp) | -- | -- | $1.3M | -$413K | -$3.4M | |
| Operating Expenses | $56.8M | $66.7M | $76.2M | $50.7M | $12.6M | |
| Operating Income | -$56.8M | -$66.7M | -$76.2M | -$50.7M | -$12.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$60M | -$66.4M | -$77.5M | -$51.6M | -$15.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$60M | -$66.4M | -$77.5M | -$51.6M | -$15.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$60M | -$66.4M | -$77.5M | -$51.6M | -$15.8M | |
| Basic EPS (Cont. Ops) | -$855.00 | -$570.00 | -$33.63 | -$299.95 | -$38.57 | |
| Diluted EPS (Cont. Ops) | -$855.00 | -$570.00 | -$33.63 | -$299.95 | -$38.57 | |
| Weighted Average Basic Share | $70.1K | $117.2K | $2.3M | $172K | $609.7K | |
| Weighted Average Diluted Share | $70.1K | $117.2K | $2.3M | $172K | $609.7K | |
| EBITDA | -$54.3M | -$64M | -$71.1M | -$48.1M | -$14.9M | |
| EBIT | -$56.1M | -$66.4M | -$74.2M | -$50.3M | -$15.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$56.8M | -$66.7M | -$76.2M | -$50.7M | -$12.6M | |
| Operating Income (Adjusted) | -$56.1M | -$66.4M | -$74.2M | -$50.3M | -$15.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11.6M | $16.3M | $14M | $3.8M | -$964K | |
| Selling, General & Admin | $3.5M | $3.3M | $2.3M | $1.4M | $1.2M | |
| Other Inc / (Exp) | -- | -- | $351K | -- | -- | |
| Operating Expenses | $15.1M | $19.6M | $16.3M | $5.2M | $253K | |
| Operating Income | -$15.1M | -$19.6M | -$16.3M | -$5.2M | -$253K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Basic EPS (Cont. Ops) | -$142.50 | -$135.50 | -$103.00 | -$24.81 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$142.50 | -$135.50 | -$103.00 | -$24.81 | -$0.05 | |
| Weighted Average Basic Share | $107.3K | $146.3K | $161.9K | $209.2K | $2.9M | |
| Weighted Average Diluted Share | $107.3K | $146.3K | $161.9K | $209.2K | $2.9M | |
| EBITDA | -$14.5M | -$18.9M | -$14.7M | -$4.5M | -$212K | |
| EBIT | -$15M | -$19.6M | -$15.5M | -$5.2M | -$253K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$15.1M | -$19.6M | -$16.3M | -$5.2M | -$253K | |
| Operating Income (Adjusted) | -$15M | -$19.6M | -$15.5M | -$5.2M | -$253K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $49.4M | $60.4M | $61.7M | $30.8M | $3.7M | |
| Selling, General & Admin | $11M | $10.9M | $11.2M | $8.8M | $3.9M | |
| Other Inc / (Exp) | -- | -- | $1.7M | -$763K | -$3.4M | |
| Operating Expenses | $60.4M | $71.3M | $72.8M | $39.6M | $7.6M | |
| Operating Income | -$60.4M | -$71.3M | -$72.8M | -$39.6M | -$7.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$63.1M | -$71.2M | -$74.4M | -$40.1M | -$10.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$63.1M | -$71.2M | -$74.4M | -$40.1M | -$10.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$63.1M | -$71.2M | -$74.4M | -$40.1M | -$10.7M | |
| Basic EPS (Cont. Ops) | -$795.00 | -$563.00 | -$447.98 | -$221.76 | -$20.07 | |
| Diluted EPS (Cont. Ops) | -$795.00 | -$563.00 | -$447.98 | -$221.76 | -$20.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$57.9M | -$68.5M | -$66.9M | -$37.9M | -$10.6M | |
| EBIT | -$59.8M | -$71M | -$70.1M | -$40M | -$10.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$60.4M | -$71.3M | -$72.8M | -$39.6M | -$7.6M | |
| Operating Income (Adjusted) | -$59.8M | -$71M | -$70.1M | -$40M | -$10.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11.6M | $16.3M | $14M | $3.8M | -$964K | |
| Selling, General & Admin | $3.5M | $3.3M | $2.3M | $1.4M | $1.2M | |
| Other Inc / (Exp) | -- | -- | $351K | -- | -- | |
| Operating Expenses | $15.1M | $19.6M | $16.3M | $5.2M | $253K | |
| Operating Income | -$15.1M | -$19.6M | -$16.3M | -$5.2M | -$253K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Basic EPS (Cont. Ops) | -$142.50 | -$135.50 | -$103.00 | -$24.81 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$142.50 | -$135.50 | -$103.00 | -$24.81 | -$0.05 | |
| Weighted Average Basic Share | $107.3K | $146.3K | $161.9K | $209.2K | $2.9M | |
| Weighted Average Diluted Share | $107.3K | $146.3K | $161.9K | $209.2K | $2.9M | |
| EBITDA | -$14.5M | -$18.9M | -$14.7M | -$4.5M | -$212K | |
| EBIT | -$15M | -$19.6M | -$15.5M | -$5.2M | -$253K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$15.1M | -$19.6M | -$16.3M | -$5.2M | -$253K | |
| Operating Income (Adjusted) | -$15M | -$19.6M | -$15.5M | -$5.2M | -$253K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $97.8M | $109.6M | $75.7M | $6.2M | $6.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.7M | $2M | $2.9M | $1.2M | $200K | |
| Total Current Assets | $99.5M | $111.7M | $78.9M | $11.3M | $8.6M | |
| Property Plant And Equipment | $9.1M | $12.1M | $12.3M | $4.8M | $452K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.3M | $1.4M | $1.3M | $1.6M | $250K | |
| Total Assets | $109.9M | $125.2M | $92.4M | $17.7M | $9.3M | |
| Accounts Payable | $3.5M | $3.5M | $6.8M | $6.3M | $7.5M | |
| Accrued Expenses | $3.2M | $3.6M | $3.4M | $4.9M | $1.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $278K | $348K | $612K | $520K | $456K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $9.5M | $10.8M | $15.1M | $15.4M | $12.6M | |
| Long-Term Debt | -- | -- | $27.4M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $11.5M | $12.8M | $46.1M | $17.6M | $13.2M | |
| Common Stock | $7K | $9K | $11K | $1K | $5K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $98.4M | $112.4M | $46.3M | $123K | -$3.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $98.4M | $112.4M | $46.3M | $123K | -$3.9M | |
| Total Liabilities and Equity | $109.9M | $125.2M | $92.4M | $17.7M | $9.3M | |
| Cash and Short Terms | $97.8M | $109.6M | $75.7M | $6.2M | $6.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $129.4M | $122.2M | $58.1M | $1.3M | $14.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.6M | $1.9M | $3M | $1.2M | $211K | |
| Total Current Assets | $131M | $124.2M | $61.1M | $9.2M | $14.9M | |
| Property Plant And Equipment | $9.6M | $11.5M | $11.5M | $4.4M | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.3M | $1.3M | $1M | $905K | -- | |
| Total Assets | $141.8M | $137M | $73.6M | $14.6M | $14.9M | |
| Accounts Payable | $2.9M | $5.5M | $6.4M | $11.3M | $6.3M | |
| Accrued Expenses | $2.2M | $2M | $3.1M | $2.5M | $1.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $284K | $358K | $629K | $570K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $6.6M | $10.8M | $12.7M | $17.4M | $11.2M | |
| Long-Term Debt | -- | $27M | $27.6M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.5M | $39.6M | $43.8M | $19.5M | $11.3M | |
| Common Stock | $8K | $10K | $1K | $1K | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $133.4M | $97.3M | $29.8M | -$4.9M | $3.6M | |
| Total Liabilities and Equity | $141.8M | $137M | $73.6M | $14.6M | $14.9M | |
| Cash and Short Terms | $129.4M | $122.2M | $58.1M | $1.3M | $14.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$60M | -$66.4M | -$77.5M | -$51.6M | -$15.8M | |
| Depreciation & Amoritzation | $1.8M | $2.3M | $3M | $2.2M | $823K | |
| Stock-Based Compensation | $3M | $3.3M | $2.3M | $568K | -$450K | |
| Change in Accounts Receivable | $4K | -$35K | -$1K | -$3.6M | $494K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$37.3M | -$53.7M | -$65.1M | -$49.5M | -$11.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.4M | -$5.4M | -$3M | $5.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $30M | -- | -- | |
| Long-Term Debt Repaid | -$15.8M | -- | -- | -$30.4M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.5M | -$1.4M | -$2.8M | -$445K | -$1.5M | |
| Cash From Financing | $78.1M | $70.8M | $34.1M | -$26.1M | $11.3M | |
| Beginning Cash (CF) | $62.4M | $98.8M | $110.6M | $76.7M | $7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $36.4M | $11.8M | -$34M | -$69.7M | -$145K | |
| Ending Cash (CF) | $98.8M | $110.6M | $76.7M | $7M | $6.8M | |
| Levered Free Cash Flow | -$41.7M | -$59M | -$68.1M | -$49.6M | -$11.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Depreciation & Amoritzation | $490K | $679K | $858K | $696K | $41K | |
| Stock-Based Compensation | $996K | $664K | $235K | $76K | $38K | |
| Change in Accounts Receivable | -$2K | $18K | $36K | -$2.9M | $185K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$15.6M | -$16.3M | -$17.8M | -$5.3M | -$1.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$458K | -$1.3M | -- | -- | $1.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $30M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$932K | -$2.7M | -- | -- | -- | |
| Cash From Financing | $47.6M | $30.2M | -- | $49K | $7.6M | |
| Beginning Cash (CF) | $98.8M | $110.6M | $76.7M | $7M | $6.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $31.6M | $12.6M | -$17.8M | -$5.3M | $7.4M | |
| Ending Cash (CF) | $130.4M | $123.2M | $58.8M | $1.7M | $14.2M | |
| Levered Free Cash Flow | -$16M | -$17.6M | -$17.8M | -$5.3M | -$1.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$63.1M | -$71.2M | -$74.4M | -$40.1M | -$10.7M | |
| Depreciation & Amoritzation | $1.9M | $2.5M | $3.2M | $2.1M | $168K | |
| Stock-Based Compensation | $3.2M | $3M | $1.9M | $409K | -$488K | |
| Change in Accounts Receivable | -$3K | -$15K | $17K | -$6.5M | $3.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$42.7M | -$54.4M | -$66.6M | -$37M | -$7.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.3M | -$6.2M | -$1.6M | $5.9M | $1.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $30M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$4.4M | -$3.1M | -- | -- | -- | |
| Cash From Financing | $120.6M | $53.5M | $3.8M | -$26M | $18.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $73.6M | -$7.2M | -$64.4M | -$57.1M | $12.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$47.1M | -$60.6M | -$68.3M | -$37M | -$7.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15M | -$19.8M | -$16.7M | -$5.2M | -$153K | |
| Depreciation & Amoritzation | $490K | $679K | $858K | $696K | $41K | |
| Stock-Based Compensation | $996K | $664K | $235K | $76K | $38K | |
| Change in Accounts Receivable | -$2K | $18K | $36K | -$2.9M | $185K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$15.6M | -$16.3M | -$17.8M | -$5.3M | -$1.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$458K | -$1.3M | -- | -- | $1.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $30M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$932K | -$2.7M | -- | -- | -- | |
| Cash From Financing | $47.6M | $30.2M | -- | $49K | $7.6M | |
| Beginning Cash (CF) | $98.8M | $110.6M | $76.7M | $7M | $6.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $31.6M | $12.6M | -$17.8M | -$5.3M | $7.4M | |
| Ending Cash (CF) | $130.4M | $123.2M | $58.8M | $1.7M | $14.2M | |
| Levered Free Cash Flow | -$16M | -$17.6M | -$17.8M | -$5.3M | -$1.4M | |
Get MBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MBIO
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
2.81x
1.81x
Price / LTM sales
--
1.67x
Growth Metrics
MBIO
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
--
8.01%
Earnings forecast
-$8.00
-$0.20
Profitability
MBIO
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
13
Balance Sheet
MBIO
Sector
Total cash
$14.2M
$35.7M
Short term investments
--
$29.7M
Total assets
$9.3M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.92% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.03% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 9.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
